Have a feature idea you'd love to see implemented? Let us know!
Back to NGNE overview

NGNE Neurogene PE ratio, current and historical analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: NGNE
  4. PE Ratio

The PE ratio for Neurogene stock stands at 0.56 as of Jan 14, 2025. This is calculated based on the TTM EPS of $31.92 and the stock price of $17.89 per share.

NGNE PE ratio history

How has NGNE's PE ratio performed in the past
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Neurogene PE ratio by year

Year PE ratio Change
2023 0.7 N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

NGNE average PE ratio chart

What is the average PE ratio of NGNE for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

NGNE PE vs peers

What is NGNE's PE ratio compared to its peers

In comparison to its peer stock ORMP, NGNE's PE ratio is lower.

Stock name PE ratio Market cap
NGNE Neurogene Inc 0.56 $265.75M
ORMP Oramed Pharmaceuticals Inc 21.45 $95.14M
OLMA Olema Pharmaceuticals Inc N/A $294.51M
OMER Omeros Corp N/A $497.79M
OMGA Omega Therapeutics Inc N/A $33.05M
ONVO Organovo Holdings Inc N/A $5.44M
ORIC Oric Pharmaceuticals Inc N/A $699.32M

Frequently asked questions

What is Neurogene's PE ratio?

NGNE's price to earnings ratio is 0.56 as of Jan 14, 2025.

Why is Neurogene's PE ratio so low?

NGNE's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.

How is NGNE's PE ratio calculated (Neurogene PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jan 14, 2025), Neurogene's share price is $17.89. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $31.92. Therefore, Neurogene's PE ratio for today is 0.56. PE RATIO(0.56) = STOCK PRICE($17.89) / TTM EPS($31.92)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.